India to produce 5 billion Covid vaccine doses next year: Piyush Goyal

Goyal said India was ready to export as many doses as partner nations require

Piyush Goyal
Piyush Goyal (Photo: PTI)
Arup Roychoudhury New Delhi
1 min read Last Updated : Dec 14 2021 | 2:00 AM IST
India plans to ramp up its Covid vaccine manufacturing capacity and expects to produce 5 billion doses of vaccines in the coming year, Commerce Minister Piyush Goyal said on Monday. Addressing an event of the Confederation of Indian Industries (CII), Goyal said India was ready to export as many doses as partner nations require. 

“So far this year, we have already administered 1.33 billion doses. We are manufacturing for exports as well. We will export as many doses as other nations need.” “Next year, we plan to produce 5 billion doses,” Goyal said.

India-UAE CEPA

India and the UAE will wrap up the Comprehensive Economic Partnership Agre­e­ment by next month, Goyal said while addressing the India Global Forum, UAE-2021 through video conference on Monday. 

“Hopefully, by the end of this month or next month, we hope to conclude them so that this would probably be one of the fastest trade agreements between two countries ever made.”

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusPiyush GoyalDelta variant of coronavirusCoronavirus VaccineVaccineVaccination

Next Story